Inhibrx Biosciences Inc.

INBX | NASDAQ

Price Alert Chart Builder DCF Calculator

$115.39

+$3.35 (+2.99%)

Sep 22, 2026, 10:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.64B

Enterprise Value $1.52B

Beta 3.67

Average Volume 349.35K

Shares Outstanding (Diluted) 15.67M

Shares Change YoY 1.3%

Institutional Ownership 81.58%

Exchange NASDAQ

ISIN US45720N1037

Price Performance

Price Change 1M 6.7%

Price Change 3M 20.6%

Price Change 6M 68.6%

Price Change YTD 49.3%

Price Change 1Y 313.1%

Price Change 3Y 589.5%

Price Change 5Y 589.5%

1M CAGR (ann.) 26.4%

1Y CAGR (ann.) 320.4%

5Y CAGR (ann.) 27.5%

All-Time CAGR 32.5%

Valuation

PE Ratio -12.62

Forward PE N/A

PEG Ratio -0.68

Forward PEG 2.07

PS Ratio N/A

Forward PS 45.60

PB Ratio -31.03

P/FCF Ratio -12.46

P/Adj. FCF Ratio -11.45

P/OCF Ratio -13.31

EV/Sales N/A

EV/EBIT -12.36

EV/EBITDA -12.58

EV/FCF -11.49

Earnings Yield -7.9%

FCF Yield -8.0%

Adj. FCF Yield -8.7%

Financial Health

Net Cash $128M

Total Debt $5.34M

Cash & Short-Term Investments $133.34M

Total Assets $154.22M

Current Ratio 5.07

Quick Ratio 5.07

Debt / Equity Ratio -0.10

Debt / EBITDA -0.04

Debt / FCF -0.04

OCF / Debt -24.69

Interest Coverage -8.21

Altman Z-Score 0.15

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.8%

Returns

Return on Assets -89.6%

Return on Equity 1893.6%

Return on Invested Capital -99.3%

Return on Capital Employed -101.3%

Return on Tangible Assets -89.6%

Historical Growth (CAGR)

Revenue CAGR 3Y -85.4%

Revenue CAGR 5Y -60.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -192.2%

EPS CAGR 5Y -9.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 14.1%

FCF CAGR 5Y -5.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 22.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$2.45

EPS Growth Est (next Q) 7.3%

Revenue Est (next Q) $1.9M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $285

Price Target Upside 154.4%

Cash Flow

Operating Cash Flow $-131.89M

Free Cash Flow $-131.87M

Adj. Free Cash Flow $-143.55M

FCF Per Share -$8.42

OCF Per Share -$8.42

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-1.68M

Operating Income $-127.81M

EBITDA $-120.45M

Net Income $-138.18M

EPS (Diluted) -$8.88

Revenue / Employee N/A

Profit / Employee $-1.26M

Employees 110